Renaissance Technologies VERTEX PHARMACEUTICALS INC ownership

VERTEX PHARMACEUTICALS INC's ticker is VRTX and the CUSIP is 92532F100. A total of 1,084 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Renaissance Technologies ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$619,293
+24.8%
2,138,885
+21.4%
0.88%
+49.0%
Q2 2022$496,280
+11.4%
1,761,168
+3.2%
0.59%
+12.4%
Q1 2022$445,572
+24.7%
1,707,368
+4.9%
0.52%
+17.8%
Q4 2021$357,260
+4.1%
1,626,868
-14.0%
0.44%
+0.2%
Q3 2021$343,097
-25.3%
1,891,486
-16.9%
0.44%
-22.7%
Q2 2021$459,169
-11.0%
2,277,284
-5.1%
0.57%
-10.7%
Q1 2021$515,797
-39.0%
2,400,284
-32.9%
0.64%
-30.1%
Q4 2020$845,135
-40.4%
3,575,930
-31.3%
0.92%
-35.1%
Q3 2020$1,416,910
-15.6%
5,206,932
-9.9%
1.42%
-2.3%
Q2 2020$1,678,378
+2.8%
5,781,332
-15.7%
1.45%
-8.6%
Q1 2020$1,632,261
+5.3%
6,859,682
-3.1%
1.58%
+33.1%
Q4 2019$1,549,418
+57.7%
7,076,582
+22.0%
1.19%
+43.1%
Q3 2019$982,486
-3.6%
5,799,117
+4.4%
0.83%
-7.2%
Q2 2019$1,018,826
+9.1%
5,555,817
+9.4%
0.90%
+5.7%
Q1 2019$934,230
+30.1%
5,078,717
+17.2%
0.85%
+8.0%
Q4 2018$718,237
-8.9%
4,334,300
+6.0%
0.79%
-3.0%
Q3 2018$788,136
-31.6%
4,089,117
-40.8%
0.81%
+28.8%
Q2 2018$1,153,085
+148.2%
6,901,534
+142.1%
0.63%
+23.8%
Q1 2018$464,642
+8.9%
2,850,917
+0.1%
0.51%
+7.9%
Q4 2017$426,789
+105.2%
2,847,917
+108.2%
0.47%
+92.2%
Q3 2017$207,994
+7339.0%
1,368,020
+6204.2%
0.24%
+6025.0%
Q2 2017$2,796
-36.3%
21,700
-45.9%
0.00%
-33.3%
Q1 2017$4,387
-15.7%
40,117
-33.7%
0.01%
-40.0%
Q2 2016$5,206
-41.8%
60,517
-46.3%
0.01%
-41.2%
Q1 2016$8,952
+16.0%
112,617
+83.7%
0.02%0.0%
Q4 2015$7,716
-58.9%
61,317
-61.5%
0.02%
-57.5%
Q1 2015$18,795
-14.9%
159,317
-49.0%
0.04%
-24.5%
Q1 2014$22,076
+109.1%
312,164
+124.2%
0.05%
+103.8%
Q3 2013$10,556139,2200.03%